![]() |
|||
|
|||
Long-term maternal outcome after pregnancy in women with
diabetic nephropathy
Warwick Bagg, Leonie Neale, Patrick Henley, Paul MacPherson
and Tim Cundy
Pregnancies complicated by diabetic nephropathy are
associated with high rates of Caesarean section, pre-term delivery, infants
small for their gestational age, congenital abnormalities and neonatal
deaths.1,2 Despite these adverse events,
short-term fetal outcomes have improved in recent years. Because of this and
because renal function in women with normal serum creatinine pre-pregnancy is
probably not adversely affected by pregnancy, women with early diabetic
nephropathy and normal serum creatinine are not now discouraged from becoming
pregnant.1–4 Although the fetal outcome
is generally good, the long-term maternal outcome also needs consideration. One
report describes one third of such patients having developed end-stage renal
failure or died ten years after their last
delivery.1
Case seriesWe have recorded prospective data on
all pregnant women with established diabetes who attended our Pregnancy Diabetes
Clinic between 1985 and 2000 and who had diabetic nephropathy defined by the
presence of both diabetic retinopathy and albuminuria (>300 mg/24 hours).
Long-term maternal outcomes were obtained from a review of hospital notes. Data
for individual pregnancies are presented as median (range). Of the 553 women
attending the clinic, 14 women (with 24 singleton pregnancies) met the
diagnostic criteria for diabetic nephropathy. The median age was 30
(19–47) years and parity 1 (0–7). There were 14 pregnancies in eight
women with Type 1, and 10 in six women with Type 2 diabetes. The median duration
of diabetes was 18.5 (3–28) years. The median serum creatinine
pre-pregnancy was 0.07 (0.04–0.12) mmol/l and at delivery was 0.07
(0.05–0.13) mmol/l. The median birth weight of the infants was 2.95
(0.73–3.78) kg at 36 (27–40) weeks. Eleven infants (46%) were
delivered at 35 weeks or before. Maternal hypertension (and associated
complications) was the primary reason for premature delivery in eight women.
Twenty infants were delivered by Caesarean section and 18 (75%) were admitted to
the special care unit for 3 (1–60) days. Three had major congenital
abnormalities. At a median follow up of 6 (1–16) years postpartum, five
women (36%) had begun dialysis for end-stage renal failure. The median time to
dialysis from the last pregnancy was 7 (3–12) years. Four of these women
had proliferative retinopathy, one of whom is now blind. Moreover, four women
treated for end-stage renal failure also suffered significant macrovascular
morbidity including ischaemic heart disease (three women), stroke (three women),
and peripheral vascular disease (two women). One of these women has now
died.
DiscussionWhile the short-term outcome from
pregnancy complicated by nephropathy is now
improved,3,4 and it is reassuring to know that
pregnancy does not accelerate the progression of diabetic renal disease in women
without renal impairment pre-pregnancy,1,5 our
data do emphasise that the long-term maternal outcome may be poor because of
diabetic complications. This reflects the long duration of diabetes and often
poor glycaemic control that these women have had. Whilst most diabetic women
will attain excellent glycaemic control in pregnancy, it typically lapses
afterwards to pre-pregnancy levels.6 We suspect
that the poor long-term maternal outcome is generally downplayed in the
pre-pregnancy counselling of women with early diabetic nephropathy, which tends
to concentrate on immediate pregnancy issues. At the least, an aggressive
approach to the management of nephropathy after delivery is mandatory.
Author information:
Warwick Bagg, Senior Lecturer in Medicine, Pregnancy Diabetes Clinic, National
Women’s Hospital and Department of Medicine, University of Auckland;
Leonie Neale, Pregnancy Diabetes Midwife; Patrick G Henley, Obstetric Physician;
Paul MacPherson, Obstetrician, Pregnancy Diabetes Clinic, National Women’s
Hospital; Tim F Cundy, Associate Professor of Medicine, Pregnancy Diabetes
Clinic, National Women’s Hospital and Department of Medicine, University
of Auckland, Auckland
Correspondence: Dr
Warwick Bagg, Department of Medicine, University of Auckland, Private Bag 92019,
Auckland. Fax: (09) 302 2101; email: w.bagg@auckland.ac.nz
References:
|
|||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |